In a recent article (Davies et al , 2000) we covered the background to and clinical presentation of the neuropsychiatric consequences of chronic exposure to organophosphates. In particular, we dicussed a syndrome that appears to develop in about 10% of chronic exposees: chronic organophosphate-induced neuropsychiatric disorder (COPIND). In this article we consider the diagnosis and management of patients with this condition, and related issues.
CITATION STYLE
Davies, R., Ahmed, G., & Freer, T. (2000). Psychiatric aspects of chronic exposure to organophosphates: diagnosis and management. Advances in Psychiatric Treatment, 6(5), 356–361. https://doi.org/10.1192/apt.6.5.356
Mendeley helps you to discover research relevant for your work.